What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant? univ_paris_cite Antiviral SARSCoV2 COVID19 Omicron
By Dr. Chinta SidharthanOct 12 2022Reviewed by Aimee Molineux In a recent article published in The Lancet, the authors commented on a recent observational study by Wong et al. , which explored the real-world effectiveness of oral antivirals against the severe acute respiratory syndrome coronavirus 2 Omicron variant.
The researchers found that molnupiravir users were older than the COVID-19 patients on nirmatrelvir plus ritonavir treatment. Nirmatrelvir plus ritonavir therapy is known to have many drug-drug interactions with prescription medications such as amiodarone, enzalutamide, rifampicin, carbamazepine, phenobarbital, St John’s Wort , phenytoin, and many more. Molnupiravir also had an earlier release date than nirmatrelvir plus ritonavir.
Commenting on the study by Wong et al., the authors stated that despite the inherent limitations of the observational study, it highlighted the relevant real-world findings of the effectiveness of the two oral antiviral therapies in preventing all-cause mortality within a community-dwelling population like Hong Kong. They mentioned that the study had a potential self-reporting bias since mildly symptomatic patients might not seek medical aid.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
What is the association of pneumococcal carriage with SARS-CoV-2 infection?What is the association of pneumococcal carriage with SARS-CoV-2 infection? medrxivpreprint UCBerkeley YaleSPH SARSCoV2 COVID19 coronavirus covid infection
Read more »
The ability of antiviral formulation ViruSAL to inhibit SARS-CoV-2 infectivityResearchers from Ireland used human bronchial epithelium models to evaluate the ability of a novel proprietary formulation called ViruSAL to inhibit SARS-CoV-2 infections.
Read more »
Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencingAbstract. Throughout the COVID-19 pandemic, control of transmission has been repeatedly thwarted by the emergence of variants of concern (VOC) and their geograp
Read more »
Pulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumoniaPulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumonia UdeGuanajuato pulmonary radiology SARSCoV2 COVID19 coronavirus covid pneumonia
Read more »
Researchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteinsIn a new study, researchers pursued direct-acting severe acute respiratory syndrome coronavirus-2 drugs that compete for nucleotide-binding pockets (NBPs) of SARS-CoV-2 proteins.
Read more »
Immune-mediated inflammatory diseases following COVID-19Immune-mediated inflammatory diseases following COVID-19 medrxivpreprint unibirmingham COVID19 SARSCoV2 InflammatoryDisease
Read more »